内分泌干扰化合物的对女性生育能力的影响
Periklis Panagopoulos1, Despina Mavrogianni2, Chryssi Christodoulaki3
1Third Department of Obstetrics and Gynecology, University Hospital "ATTIKON", Medical School of the National and Kapodistrian University of Athens, Greece.
概括
内分泌干扰化合物 (EDC) 通过干扰荷尔蒙作用,对女性生育产生负面影响,导致流产和辅助生殖技术 (ART) 成功率较低等问题. 本综述审查了关于EDC对生殖健康影响的最新文献.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 生殖生物学 生殖生物学
背景情况:
- 内分泌干扰化合物 (EDC) 是干扰激素系统的化学物质.
- 许多EDC,包括杀虫剂,酸盐和像BPA这样的双,在环境中广泛存在.
- 这些化合物可以模仿或阻止自然激素的作用,破坏生理功能.
研究的目的:
- 审查最近关于EDCs对女性生育能力影响的科学文献.
- 突出EDCs影响生殖健康的机制.
- 确定常见的EDC及其对女性生殖的特定不良影响.
主要方法:
- 关于EDC和女性生育能力的最新研究的文献综述.
- 分析着重于类固醇生成,流产,受精和胚胎植入的研究.
- 检查与辅助生殖技术 (ART) 结果相关的数据.
主要成果:
- EDCs与破坏的类固醇生成和流产率的增加有关.
- 对某些EDC的暴露与较低的受精率和胚胎植入率相关.
- 一些EDC可能会减少ART怀孕中高质量的胚胎的数量.
结论:
- 通过各种机制,EDC对女性生育能力构成重大威胁.
- 双A (BPA) 是一个突出的EDC,对女性生殖系统有着充分记录的负面影响.
- 需要进一步的研究和监管措施来减轻EDCs对生殖健康的影响.
相关概念视频
Infertility in Females
355
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
355
Oogenesis
63.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.9K
Infertility in Males
299
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
299
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Spermatogenesis
102.7K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.7K
Disorders of the Female Reproductive System
421
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
421


